TipRanks
Go Ultimate55% OFF

Top Page

XT

iShares Exponential Technologies ETF (XT)

Rating:69Neutral
Price Target:$92.00â–²(10.14% Upside)

XT’s rating suggests it is a solid but not top-tier ETF, driven largely by strong, diversified leaders like Microsoft, Texas Instruments, Nvidia, and Johnson & Johnson, which benefit from robust financial performance and growth in areas such as cloud, AI, and advanced semiconductors. The fund’s score is held back somewhat by holdings like CrowdStrike and Amazon, where valuation and profitability or cash flow challenges introduce caution. A key risk factor is its heavy focus on high-growth technology names, which can mean higher volatility and sensitivity to market sentiment.

Positive Factors
Strong Recent PerformanceThe ETF has delivered solid gains so far this year and over the past three months, showing positive momentum.
Leading Technology and Healthcare NamesSeveral top holdings in technology and healthcare, such as major chipmakers and drug companies, have shown strong or steady performance, helping support the fund’s returns.
Broad Sector and Global SpreadWhile tilted toward technology and healthcare, the fund also holds companies across multiple sectors and countries, which helps spread risk beyond any single industry or region.
Negative Factors
Heavy Tilt to U.S. MarketWith most assets in U.S. companies, the ETF is heavily tied to the U.S. market and offers limited diversification if U.S. stocks struggle.
Concentration in Tech and HealthcareA large share of the portfolio sits in technology and healthcare, which can make the fund more sensitive to swings in these growth-oriented sectors.
Mixed Performance Among Top HoldingsSome major positions, including well-known technology and auto names, have recently shown weak performance, which could weigh on future returns if the trend continues.

XT vs. SPDR S&P 500 ETF (SPY)

AUM
3.96B
Region
Global
Expense Ratio
0.46%
Beta
1.10
Issuer
iShares
Inception Date
Mar 19, 2015
Dividend Yield
6.81%
Asset Class
Equity
Index Tracked
Morningstar Exponential Technologies Index

XT Summary

The iShares Exponential Technologies ETF (XT) tracks the Morningstar Exponential Technologies Index, focusing on companies using cutting-edge tools like robotics, artificial intelligence, and advanced healthcare technology. It holds many U.S. stocks and mixes tech and health care names, including well-known companies like Microsoft, Nvidia, Amazon, and Eli Lilly. Someone might invest in XT to seek long-term growth and diversify across many innovative businesses in one fund. A key risk is that it’s heavily tied to technology and future-focused companies, so its price can be more volatile and can go up and down sharply with market sentiment.

How much will it cost me?

The iShares Exponential Technologies ETF (XT) has an expense ratio of 0.46%, meaning you’ll pay $4.60 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it is actively managed to focus on innovative and emerging technologies, which require more research and specialized expertise.

What would affect this ETF?

The iShares Exponential Technologies ETF (XT) could benefit from continued advancements in technology, such as artificial intelligence and robotics, which are driving innovation across industries globally. However, it may face challenges from rising interest rates, which can impact growth-focused companies, and potential regulatory changes affecting key sectors like healthcare and technology. Its global exposure and diversified holdings provide resilience, but economic slowdowns or geopolitical tensions could negatively affect its performance.

XT Top 10 Holdings

XT is leaning heavily into U.S.-centric, next‑gen tech, with semiconductor names like Texas Instruments, Nvidia, and Analog Devices doing much of the heavy lifting as their shares keep rising. Cybersecurity stars Palo Alto Networks and CrowdStrike are also powering ahead, giving the fund a strong AI and digital-defense flavor. On the flip side, Tesla is dragging the ETF, with its recent performance losing steam, while Eli Lilly and Amazon look more mixed. Overall, the fund is globally themed but practically anchored in American innovation and exponential technologies.

XT top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
LLYLLYEli Lilly & Co4.34%$173.59M$1.21T58.93%72Outperform
MSFTMSFTMicrosoft4.19%$167.46M$3.95T2.95%79Outperform
TXNTXNTexas Instruments4.27%$170.44M$253.68B57.40%78Outperform
TSLATSLATesla4.29%$171.37M$1.53T-12.68%73Outperform
NVDANVDANvidia3.79%$151.29M$5.22T22.53%76Outperform
PANWPANWPalo Alto Networks3.22%$128.84M$278.35B61.96%73Outperform
ADIADIAnalog Devices3.22%$128.81M$192.40B64.78%78Outperform
JNJJNJJohnson & Johnson2.94%$117.60M$621.22B34.34%78Outperform
AMZNAMZNAmazon2.76%$110.16M$2.83T18.17%71Outperform
ABBVABBVAbbVie2.47%$98.53M$510.84B23.08%66Neutral

XT Technical Analysis

Technical Analysis SentimentPositive
Last Price83.53

Price Trends

50DMA82.95Positive
100DMA82.05Positive
200DMA77.47Positive

Market Momentum

MACD0.01Positive
RSI51.51Neutral
STOCH35.72Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XT, the sentiment is Positive. The current price of 83.53 is below the 20-day moving average (MA) of 83.76, above the 50-day MA of 82.95, and above the 200-day MA of 77.47, indicating a neutral trend. The MACD of 0.01 indicates Positive momentum. The RSI at 51.51 is Neutral, neither overbought nor oversold. The STOCH value of 35.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XT.

XT Peer Comparison

Comparison Results

XT against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
XTXT$83.53$92.00(10.14% Upside)$3.96B0.46%69Neutral
GUNRGUNR$54.17$60.78(12.19% Upside)$7.10B0.46%59Neutral
GNRGNR$76.38$85.81(12.35% Upside)$5.40B0.40%64Neutral
HACKHACK$122.21$135.52(10.89% Upside)$3.35B0.60%68Neutral
FWDFWD$125.61$158.36(26.07% Upside)$3.25B0.65%64Neutral
NFRANFRA$63.50$73.94(16.44% Upside)$3.01B0.47%66Neutral

Performance Comparison

0%20%40%XTGUNRGNRHACKFWDNFRANov '25Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
XT and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
XTiShares Exponential Technologies ETF83.5315.0722.01%
GUNRFlexShares Morningstar Global Upstream Natural Resources Index Fund54.1711.2726.26%
GNRSPDR S&P Global Natural Resources ETF76.3818.4631.87%
HACKEtfmg Prime Cyber Security Etf122.2134.8539.90%
FWDAB Disruptors ETF125.6120.7819.83%
NFRAFlexShares STOXX Global Broad Infrastructure Index Fund63.503.966.65%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.